AN-2690
| CAS No. | 174671-46-6 | Cat. No. | BCP08730 |
| Name | AN-2690 | ||
| Synonyms | Tavaborole; AN2690; AN 2690； Kerydin; | ||
| Formula | C7H6BFO2 | M. Wt | 151.93 |
| Description | AN-2690, a broad-spectrum drug, is a very promising candidate for treatment of ungual and periungual infections with improved nail penetration and low keratin binding. AN-2690 is an antifungal agent with activity against Trichophyton species. AN-2690 inhibits yeast cytoplasmic leucyl-tRNA synthetase by formation of a stable tRNA(Leu)-AN2690 adduct in the editing site of the enzyme. AN-2690 is currently in clinical trials for onychomycosis topical treatment. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antifungal | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.